CHEBI:69228 - caerulomycin I

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name caerulomycin I
Definition A pyridine alkaloid that is 2,2ʼ-bipyridine-6-carboxamide substituted by methoxy groups at position 4 and carbamoyl nitrogen respectively. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C13H13N3O3
Net Charge 0
Average Mass 259.26060
Monoisotopic Mass 259.09569
InChI InChI=1S/C13H13N3O3/c1-18-9-7-11(10-5-3-4-6-14-10)15-12(8-9)13(17)16-19-2/h3-8H,1-2H3,(H,16,17)
SMILES CONC(=O)c1cc(OC)cc(n1)-c1ccccn1
Metabolite of Species Details
Actinoalloteichus cyanogriseus (NCBI:txid65497) Ethyl acetate extract of fermentation broth of strain WH1 2216-6 See: PubMed
Roles Classification
Biological Role(s): bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
marine metabolite
Any metabolite produced during a metabolic reaction in marine macro- and microorganisms.
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing caerulomycin I (CHEBI:69228) has parent hydride 2,2'-bipyridine (CHEBI:30351)
caerulomycin I (CHEBI:69228) has role antineoplastic agent (CHEBI:35610)
caerulomycin I (CHEBI:69228) has role bacterial metabolite (CHEBI:76969)
caerulomycin I (CHEBI:69228) has role marine metabolite (CHEBI:76507)
caerulomycin I (CHEBI:69228) is a aromatic ether (CHEBI:35618)
caerulomycin I (CHEBI:69228) is a bipyridines (CHEBI:50511)
caerulomycin I (CHEBI:69228) is a pyridine alkaloid (CHEBI:26416)
caerulomycin I (CHEBI:69228) is a pyridinecarboxamide (CHEBI:25529)
Registry Number Type Source
21856155 Reaxys Registry Number Reaxys
Citation Waiting for Citations Type Source
21770434 PubMed citation Europe PMC
Last Modified
02 December 2013